Trupanion, Inc. (TRUP.MX) balance sheet
This article provides the balance sheet for Trupanion, Inc. (TRUP.MX) with financial data presented in thousands of USD. It includes annual and quarterly breakdowns of key metrics such as total assets, total liabilities, total equity, and various capital figures from 2022 to 2025. The data also details common stock equity, net tangible assets, working capital, and total debt for the specified years.
Why Trupanion (TRUP) Is Back In The Spotlight
Trupanion (TRUP) is gaining attention after a recent stock decline, despite a strong long-term outlook from analysts who believe it is 31% undervalued with a fair value of $34.25. While the company focuses on improving underwriting and subscriber growth, a contrasting view highlights its high P/E ratio of 44.8x compared to the industry average of 10.6x, raising questions about its current valuation. Investors are encouraged to assess both the potential for growth and existing risks before making investment decisions.
TRUP Lags Industry, Trades at a Premium: What Should Investors Know?
Shares of Trupanion Inc. (TRUP) have underperformed its industry, sector, and the Zacks S&P 500 composite year to date, largely due to slower pet growth and rising costs. Despite being overvalued compared to its industry, TRUP is well-positioned for growth due to high customer retention, recurring revenues, and international expansion efforts. However, given its premium valuation and muted analyst sentiment, a wait-and-see approach is recommended for this Zacks Rank #3 (Hold) stock.
BofA Securities Maintains Trupanion(TRUP.US) With Buy Rating, Announces Target Price $42
BofA Securities has reiterated its Buy rating for Trupanion (TRUP.US). The firm has also set a target price of $42 for the company's stock.
Form 4 Trupanion Inc For: 30 September
This article reports on a Form 4 filing for Trupanion Inc. for the period ending September 30. It provides this information within the context of general market news and company data.
Form 4 Trupanion Inc For: 30 September By Investing.com
This article announces the filing of a Form 4 for Trupanion Inc., pertaining to the period ending September 30. Form 4 filings typically disclose changes in beneficial ownership of a company's stock by its insiders. The article provides this financial news without further details within its body.
Form 144 TRUPANION For: 29 September By Investing.com
This article announces the filing of Form 144 for TRUPANION on September 29, 2026. The content is brief and serves primarily as a notification about this specific financial filing for the company.
Form 144 TRUPANION For: 29 September By Investing.com
The article reports on a Form 144 filing for TRUPANION (TRUP) dated September 29. Form 144 is a notice of the intent to sell restricted securities. The article provides no further details on the filing beyond its existence and date.
Trupanion, Inc. (NASDAQ:TRUP) Stock Now Rated "Hold" by Sell-Side Analysts
Trupanion, Inc. (NASDAQ:TRUP) has received a consensus "Hold" rating from sell-side analysts, with an average 12-month price target of $39.20. Recent reports show some firms lowering their ratings and price targets for the pet insurance company. Despite recent insider selling and stock performance near its 52-week low, Trupanion reported strong quarterly revenue and earnings that exceeded analyst expectations.
Three prior sales precede a proposed $9,878.52 share sale by Trupanion (NASDAQ: TRUP) officer John Gallagher.
Trupanion officer John Gallagher has reported a proposed sale of 431 common shares, valued at $9,878.52, scheduled for September 28, 2026. These shares were acquired between November 2023 and February 2024 through the vesting of restricted stock. The filing also notes three previous sales by Gallagher in June, July, and August 2026.
Trupanion, Inc. $TRUP Shares Newly Acquired by Bank of America Corp DE
Bank of America Corp DE recently acquired 575,764 shares of Trupanion, Inc. (TRUP) during the second quarter, a stake valued at approximately $14.3 million. Trupanion reported strong quarterly earnings, exceeding analyst expectations with an EPS of $0.16 and an 11.1% increase in revenue year-over-year. Despite institutional interest, analysts maintain a "Hold" rating for TRUP, and insiders have sold shares totaling over $381,000 in the past 90 days.
Trupanion Inc (TRUP) Stock Up 3.3% and Still Undervalued -- GF S
Trupanion Inc (TRUP) stock rose 3.3% to $23.16, yet remains significantly undervalued according to its GF Value™ of $40.60. Despite a GF Score™ of 78/100, indicating above-average performance, notable insider selling of $3.4 million suggests caution. Investors are advised to consider the undervaluation as an opportunity but also heed the insider activity and broader market conditions.
Trupanion, Inc. (TRUP) Stock Price, News, Quote & History
This article provides detailed financial information for Trupanion, Inc. (TRUP), a pet insurance provider. It covers the current stock price, recent performance metrics, key financial data, and analyst insights. The company, founded in 2000 and headquartered in Seattle, offers medical insurance for cats and dogs across North America and Europe.
Primerica, Progressive, Allstate, and Trupanion Shares Are Falling, What You Need To Know
Shares of insurance companies Primerica, Progressive, Allstate, and Trupanion fell after Allstate reported significant catastrophe losses from recent severe weather events, impacting investor sentiment across the sector. The market is reacting to the potential for higher claims costs and pressure on margins due to an active severe-weather season. While these price drops are significant, the article suggests they might present buying opportunities for high-quality stocks.
Trupanion, Inc. - Common Stock (NQ: TRUP)
This page provides the latest news and stock information for Trupanion, Inc. (TRUP), including recent articles from various financial news outlets. It features a snapshot of the stock's current trading performance and links to detailed quotes, charting, and historical prices. The content compiles news headlines and press releases dating back several months, covering topics like stock performance, analyst ratings, and company initiatives.
Trupanion CEO Margaret Tooth Executes Sale of 1,000 Shares Under 10b5-1 Plan
Trupanion CEO and Director Margaret Tooth sold 1,000 shares of the company's common stock on September 11, 2026, at $25 per share. This transaction was executed under a pre-arranged Rule 10b5-1 trading plan adopted on May 11, 2026, for financial diversification. Following the sale, Ms. Tooth directly holds 185,952 shares of Trupanion stock.
Insider Selling: Trupanion (NASDAQ:TRUP) CEO Sells $25,000.00 in Stock
Trupanion CEO Margaret Tooth sold 1,000 shares of the company's stock for $25,000 on September 11th, reducing her stake by 0.53%. This transaction was part of a pre-arranged Rule 10b5-1 trading plan. The company recently reported strong quarterly earnings, beating analyst estimates, but its stock price is significantly below its 52-week high, and analyst sentiment remains cautious with a "Hold" rating.
1,000 Trupanion (NASDAQ: TRUP) shares set for September 2026 sale
Margaret R. Tooth, a security holder of Trupanion (NASDAQ: TRUP), has filed a Rule 144 notice to sell 1,000 common shares. These shares, previously received as restricted stock, have an aggregate market value of $25,000 and are expected to be sold through Morgan Stanley Smith Barney LLC on NASDAQ around September 11, 2026. The filing also indicates a prior sale of 978 shares by the same individual in the past three months for proceeds of $28,410.90.
Ten pets will become Trupanion’s faces in 2027. Members have 10 days to enter.
Trupanion (TRUP) has launched its annual truFame contest, inviting pet owners across North America to submit photos and stories of their pets for a chance to become "It Pets" in 2027. Ten winning pets will be featured in Trupanion's marketing and community campaigns. Submissions are open from September 10-20, 2026, with public voting from September 24 to October 6, 2026.
Legal & General Group Plc Acquires Shares of 78,246 Trupanion, Inc. $TRUP
Legal & General Group Plc has acquired 78,246 shares of Trupanion, Inc. (NASDAQ:TRUP) valued at approximately $1.94 million, representing about 0.18% of the company. This comes as other institutional investors, including BlackRock Inc., have also significantly increased their positions in Trupanion. Despite recent downgrades from some analysts, Trupanion reported strong quarterly earnings, beating estimates with $0.16 per share and an 11.1% increase in revenue year over year.
186,945 Shares in Trupanion, Inc. $TRUP Purchased by Bank of New York Mellon Corp
Bank of New York Mellon Corp has purchased 186,945 shares of Trupanion, Inc. (NASDAQ:TRUP) valued at approximately $4.63 million, making it a new stakeholder in the pet medical insurance company. This acquisition comes as Trupanion reported strong quarterly earnings, beating analyst estimates with $0.16 EPS and an 11.1% increase in revenue year-over-year. Despite recent insider selling, Trupanion maintains a consensus "Hold" rating from analysts with an average price target of $39.20.
Susquehanna Fundamental Investments LLC Invests $1.68 Million in Trupanion, Inc. $TRUP
Susquehanna Fundamental Investments LLC has acquired a new stake in Trupanion, Inc. (NASDAQ:TRUP) worth approximately $1.68 million during the second quarter. Despite this investment, analyst sentiment for Trupanion remains cautious, with an average "Hold" rating and a consensus price target of $39.20. The company recently surpassed quarterly earnings expectations, reporting $0.16 EPS against an expected $0.11 and an 11.1% increase in revenue year-over-year.
Trupanion COO John Gallagher sells $107,038 in TRUP stock By Investing.com
Trupanion COO John R. Gallagher sold 3,604 shares of TRUP stock for approximately $107,038 on August 28, 2026, under a pre-established Rule 10b5-1 trading plan for financial diversification. Following the sale, Gallagher retains 33,742 shares. The stock has since declined, though InvestingPro analysis suggests it is undervalued with a "GOOD" financial health rating.
Trupanion COO John Gallagher sells $107,038 in TRUP stock By Investing.com
Trupanion COO John R. Gallagher sold 3,604 shares of TRUP stock for approximately $107,038 on August 28, 2026, under a pre-established Rule 10b5-1 trading plan for financial diversification. Following the sale, Gallagher directly holds 33,742 shares. Despite a recent stock decline, InvestingPro suggests the stock is undervalued, and the company recently exceeded Q2 2026 profit forecasts while facing a rating downgrade from Piper Sandler and a price target adjustment from Stifel due to strategic changes.
5,441,008 Shares in Trupanion, Inc. $TRUP Acquired by BlackRock Inc.
BlackRock Inc. recently acquired 5.44 million shares of Trupanion, Inc. (NASDAQ:TRUP) valued at approximately $134.8 million, securing a 12.47% stake in the pet insurance company. Despite this significant investment, analyst sentiment for Trupanion remains cautious, with a consensus "Hold" rating and an average price target of $39.20. The company, however, exceeded quarterly earnings expectations, reporting $0.16 EPS against a $0.11 forecast, and achieved $392.9 million in revenue, an 11.1% increase year-over-year.
Deutsche Bank AG Takes Position in Trupanion, Inc. $TRUP
Deutsche Bank AG has acquired a new stake of 74,260 shares in Trupanion, Inc. (NASDAQ:TRUP), valued at approximately $1.84 million, as reported in its recent SEC filing. This acquisition represents about 0.17% of Trupanion's stock, with other institutional investors also increasing their positions. Despite the increased institutional interest and Trupanion exceeding quarterly earnings and revenue estimates, analyst sentiment remains cautious with a consensus "Hold" rating, and insiders have sold shares worth nearly $396,000.
Trupanion CEO Margaret Tooth sells $15,633 in company stock
Trupanion CEO Margaret Tooth sold $15,633 worth of company stock, involving 491 shares at $31.84 each. This transaction occurred amidst other stock activity, including the conversion of RSUs into 19,042 shares and the disposition of 6,000 shares for tax obligations. The company's stock is considered undervalued by InvestingPro, despite a year-to-date decline, and recently reported strong Q2 2026 earnings.
Trupanion CFO Fawwad Qureshi sells shares worth $183,391
Trupanion CFO Fawwad Qureshi sold 6,111 shares of company stock for $183,391 on August 26, 2026, after acquiring 13,746 shares through RSU conversions. Following the transactions and tax withholdings, Qureshi directly owns 4,230 shares. The sale occurred while Trupanion's stock is down 19% year-to-date, though it is considered undervalued by InvestingPro analysis, and the company recently surpassed profit expectations despite mixed analyst ratings.
Piper Sandler Downgrades Trupanion, Inc. (TRUP) to Neutral
Piper Sandler analyst David Westenberg has downgraded Trupanion, Inc. (NASDAQ: TRUP) from an Overweight rating to Neutral. The price target for TRUP has been set at $32.00 following this downgrade. The article indicates this is a premium content piece, requiring a subscription to StreetInsider.com Premium for full access.
Piper Sandler cuts Trupanion stock rating on macro headwinds
Piper Sandler downgraded Trupanion (NASDAQ:TRUP) to Neutral from Overweight and lowered its price target, citing concerns about macro headwinds, including a contraction in puppy vet visits and the aging of the COVID pet cohort. Despite maintaining a strong competitive position and reputation, the firm is moving to the sidelines due to challenges in balancing premium growth, member retention, and new-pet acquisition. This downgrade reflects near-term pressures rather than a change in the company's long-term competitive standing.
Trupanion (TRUP) Expands With Home To Home, Is The Stock Still A Bargain?
Trupanion (TRUP) has partnered with Home To Home to provide pet adopters with education on veterinary costs and immediate medical insurance access, causing a recent surge in its stock price. While the company is considered 14.5% undervalued by some analysts with a fair value of $37.25, its current P/E ratio of 60.2x is significantly higher than the US Insurance industry average, raising questions about its valuation. Investors are encouraged to assess the underlying forecasts and potential risks before making investment decisions.
Trupanion(TRUP) Stock Options Chain | Quotes & News
The article provides a stock options chain for Trupanion (TRUP). It includes quotes and news related to the company's stock performance and options trading.
Stifel raises Trupanion stock price target on Pets Best exit
Stifel increased its price target for Trupanion (NASDAQ:TRUP) to $29.00 from $28.00, while maintaining a Hold rating, following Trupanion's announcement to end its partnership with Pets Best by Q3 2028. Pets Best represented a significant portion of Trupanion's 2025 revenue. The adjustment reflects the anticipated decline in revenue from this segment, though the company is expected to remain profitable, and recently surpassed Q2 2026 earnings expectations.
TRUP Maintained by Stifel -- Price Target Raised to $29.00
Stifel has maintained a "Hold" rating for Trupanion (TRUP) but raised its price target from $28.00 to $29.00. GuruFocus indicates TRUP is 22.7% undervalued with a GF Value of $40.26 and a strong GF Score of 79/100, though insider selling has been noted.
Stifel raises Trupanion stock price target on Pets Best exit
Stifel increased its price target for Trupanion (NASDAQ:TRUP) to $29.00 from $28.00 while maintaining a Hold rating, following Trupanion's announcement to end its partnership with Pets Best by Q3 2028. Pets Best represented a significant portion of Trupanion's 2025 revenue, and the model projects a gradual decline in this segment. Despite the adjustment, the company is expected to remain profitable, as supported by its recent Q2 2026 earnings which surpassed expectations.
Trupanion, Inc. (TRUP) PT Raised to $29 at Stifel as Pets Best Rolls Off Business
Stifel analyst Jonathan Block increased the price target for Trupanion, Inc. (TRUP) to $29.00 from $28.00, while maintaining a Hold rating. This adjustment follows the agreement between Trupanion and Pets Best to conclude their relationship after Q3 2028, which is expected to result in a material revenue headwind as Pets Best accounted for 30% of Trupanion's total 2025 revenue. Despite the revenue loss, the adjusted operating income from the "Other" business segment (which included Pets Best) was only 1-2% of segment revenue, and the analyst's model anticipates a gradual decline to zero by the end of 2033, with a focus on winding down fixed costs.
Is Trupanion (TRUP) Undervalued Following Its New Pet Care Partnerships?
Trupanion (TRUP) has garnered attention due to new partnerships aimed at improving pet care through insurance education and easier claims, leading to recent share price increases. While a popular narrative suggests the stock is 17.9% undervalued with a fair value of $37.25, another view points to its high P/E ratio of 57.8x compared to industry averages, indicating investors are already paying a significant premium for its earnings. The article advises investors to further analyze the data given the split sentiment between valuation concerns and future optimism.
GSA Capital Partners LLP Purchases Shares of 56,264 Trupanion, Inc. $TRUP
GSA Capital Partners LLP recently acquired 56,264 shares of Trupanion, Inc. for approximately $1.39 million, establishing a new position in the company. This comes as other institutional investors have increased their holdings, despite some insider selling. Trupanion surpassed quarterly earnings expectations with adjusted EPS of $0.16 and revenue of $392.93 million, leading analysts to maintain a "Moderate Buy" rating with a target price of $41.60.
Trupanion Inc. Earnings Call Highlights Growth Momentum
Trupanion Inc. reported strong Q2 earnings, with total revenue up 11% year-over-year and adjusted operating income climbing 24%. The company highlighted accelerating pet enrollment, improved unit economics, and significant free cash flow generation, demonstrating confidence in its ability to navigate industry challenges like veterinary inflation. Despite a decrease in net income attributed to a non-recurring gain last year and a transition risk with partner Pets Best, Trupanion provided optimistic 2026 guidance, projecting continued double-digit growth.
Trupanion (TRUP) Is Up 13.4% After New Vet Partnerships and Q2 Results - Has The Bull Case Changed?
Trupanion (TRUP) stock rose 13.4% following its Q2 2026 results, which included updated revenue guidance and new partnerships with Digitail and Home To Home. These collaborations aim to integrate Trupanion's VetDirect Pay and Exam Day coverage into veterinary workflows and pet rehoming processes, reinforcing its margin-focused, subscription-driven growth strategy. While analysts forecast significant revenue and earnings growth by 2029, a $37.25 fair value suggests a 22% upside, though competitive pressures and rising veterinary costs pose potential risks.
Trupanion (TRUP) Is Up 13.4% After New Vet Partnerships and Q2 Results - Has The Bull Case Changed?
Trupanion (TRUP) saw a 13.4% stock increase following its Q2 2026 results, which reported net income of US$6.83 million and updated revenue guidance. The company also announced new partnerships with veterinary software provider Digitail and rehoming platform Home To Home, aiming to integrate its services deeper into the pet care journey. These strategic moves are expected to reinforce Trupanion's subscription-driven investment narrative by improving pet acquisition quality and potentially claim efficiency, supporting its margin-focused growth strategy amidst ongoing market competition.
Renaissance Technologies LLC Has $999,000 Stake in Trupanion, Inc. $TRUP
Renaissance Technologies LLC significantly increased its stake in Trupanion, Inc. by 550% in the first quarter, now holding 39,000 shares valued at approximately $999,000. Trupanion received a "Moderate Buy" consensus rating from analysts with an average price target of $41.60, after reporting strong quarterly earnings of $0.16 EPS against estimates of $0.11, and an 11.1% increase in revenue year-over-year. Despite insider stock sales by the CFO and EVP, institutional investors generally show increased interest in the pet medical insurance provider.
Trupanion CEO Margaret Tooth sells $28,410 in company stock
Trupanion CEO Margaret Tooth sold 978 shares of company stock worth $28,410 on August 11, 2026, as part of a pre-scheduled diversification plan. Following the sale, she still holds 175,401 shares. Despite the insider sale and a 39% decline over the past year, the stock recently gained 10% and is considered undervalued by InvestingPro analysts, with the company also exceeding Q2 2026 profit expectations.
5 Must-Read Analyst Questions From Trupanion’s Q2 Earnings Call
Trupanion reported better-than-expected Q2 2026 results, driven by increased pet enrollments and improved web conversion. Revenue reached $392.9 million, exceeding analyst estimates, and GAAP EPS hit $0.16. Key analyst questions focused on veterinary inflation, credit facility usage, the share repurchase program, and the impact of new product rollouts, with management providing insights into these strategic areas.
Trupanion CEO Margaret Tooth sells $28,410 in company stock By Investing.com
Trupanion CEO Margaret Tooth sold 978 shares of company stock for $28,410 on August 11, 2026, as part of a pre-scheduled diversification plan. Despite the stock trading 39% down over the past year, InvestingPro analysis suggests it is undervalued with a PEG ratio of 0.5. The sale follows a strong Q2 2026 earnings report where Trupanion exceeded profit expectations and saw an 11% revenue increase.
Margaret Tooth Sells 978 Shares of Trupanion (NASDAQ:TRUP) Stock
Trupanion CEO Margaret Tooth recently sold 978 shares of the company's stock for a total of $28,410.90 under a pre-arranged Rule 10b5-1 plan. Following the transaction, her ownership stands at 175,401 shares. The company's stock traded up 2.2% to $31.00, and Trupanion reported strong quarterly earnings, beating analyst expectations with an EPS of $0.16 and revenue of $392.93 million.
Trupanion Partners with Home To Home® to Help More Pets Transition Directly from One Loving Home to Another
Trupanion, a leading pet insurer, has announced a partnership with Home To Home®, a direct pet rehoming platform. This collaboration aims to provide new pet families with educational resources, guidance on veterinary expenses, and access to Trupanion's Exam Day Offer, which offers immediate comprehensive coverage. The partnership seeks to support pets transitioning to new homes while also alleviating pressure on animal shelters.
Trupanion Partners with Home To Home® to Help More Pets Transition Directly from One Loving Home to Another
Trupanion, a leading pet insurer, has announced a new partnership with Home To Home®, a direct pet rehoming platform. This collaboration aims to support pets and new families by providing educational resources on veterinary expenses and offering an exclusive Exam Day Offer for immediate comprehensive coverage. The partnership helps ease pet transitions into new homes while assisting shelters by reducing owner surrenders.
Zacks Industry Outlook Highlights Aflac, Globe Life, Trupanion and Employers Holdings
The Zacks Accident and Health Insurance industry is expected to benefit from increased underwriting exposure, with Aflac, Globe Life, Trupanion, and Employers Holdings poised for growth due to rising demand for group insurance. However, the industry faces challenges from persistent medical inflation and pricing pressures, despite advancements in technology like AI and improved claims frequency. The industry currently holds a Zacks Industry Rank #214, indicating bleak near-term prospects despite individual company advancements.
Trupanion (NASDAQ: TRUP) investor files to sell 978 common shares
A Trupanion (NASDAQ: TRUP) shareholder, Margaret R. Tooth, has filed an intention to sell 978 common shares through Morgan Stanley Smith Barney LLC Executive Financial Services. The planned sale, valued at $28,410.90, is scheduled for August 11, 2026, on NASDAQ. This disclosure also notes a previous sale of 491 shares on May 25, 2026, and details restricted stock awards from 2021 and 2022.
